Amino-terminal acetylation is one of the most common protein modifications, occurring co- and post-translationally. Approximately 80% of cytosolic proteins are amino-terminally acetylated in humans and ~50% in yeast (Arnesen et al., 2009), while amino-terminal acetylation is less common in prokaryotes and archaea (Dörfel and Lyon, 2015). Amino-terminal acetylation is catalyzed by a set of enzymes, the N-terminal acetyltransferases (NATs), which transfer an acetyl group from acetyl-coenzyme A (Ac-CoA) to the free α-amino group of a protein’s N-terminus. To date, eight distinct NATs (NatA–NatH) have been identified in eukaryotes that are classified based on different subunit compositions and substrate specificities (Polevoda et al., 2009; Aksnes et al., 2019; Starheim et al., 2012). Amino-terminal acetylation has been implicated in steering protein folding, stability or degradation, subcellular targeting, and complex formation (Ree et al., 2018; Shemorry et al., 2013; Dikiy and Eliezer, 2014; Holmes et al., 2014; Scott et al., 2011). The vital role of NATs and amino-terminal acetylation in development has also emerged (Lee et al., 2018).

NatA, the major NAT complex, targets ~40% of the human proteome, acetylating Ser-, Ala-, Gly-, Thr-, Val-, and Cys N-termini after removal of the initiator methionine (Arnesen et al., 2009; Starheim et al., 2012). Human NatA consists of two main subunits, the catalytic subunit N-α-acetyltransferase 10 (NAA10) (Ard1) and the auxiliary subunit NAA15 (Nat1), and a regulatory subunit HYPK (Arnesen et al., 2005; Arnesen et al., 2010; Gottlieb and Marmorstein, 2018). NAA15 function has been linked to cell survival, tumor progression, and retinal development (Arnesen et al., 2006a; Gendron et al., 2010). In addition, Naa10-catalyzed N-terminal acetylation has been reported to be essential for development in many species (Lee et al., 2018; Wang et al., 2010; Chen et al., 2014; Linster et al., 2015; Ree et al., 2015; Feng et al., 2016; Chen et al., 2018), and although NatA is not essential in Saccharomyces cerevisiae, depletion of Naa10 or Naa15 has strong effects, including slow growth and decreased survival when exposed to various stresses (Mullen et al., 1989; Polevoda and Sherman, 2003).

NAA10 mutations were found to be associated with several human diseases characterized by severe phenotypes, including global developmental defects (Lee et al., 2018). Among these, the X-linked Ogden syndrome (OS) (Myklebust et al., 2015; Rope et al., 2011) shows the most severe pathological features such as infant lethality and has reduced NatA catalytic activity. In a S. cerevisiae model for the Naa10 Ser37Pro mutant, the mutation impairs NatA complex formation and leads to a reduction in NatA catalytic activity and functionality (Van Damme et al., 2014; Dörfel et al., 2017). Further, OS patient-derived cells have impaired amino-terminal acetylation in vivo of some NatA substrates (Myklebust et al., 2015). Over the years, many additional pathogenic NAA10 variants have been identified in NAA10 or NAA15 (Esmailpour et al., 2014; Popp et al., 2015; Casey et al., 2015; McTiernan et al., 2018; Ree et al., 2019; Støve et al., 2018; Cheng et al., 2019; Cheng et al., 2018; Johnston et al., 2019) and the collection of presenting symptoms for families with NAA10 mutations is currently referred to as Ogden syndrome or NAA10-related syndrome (Wu and Lyon, 2018).

The autosomal NAA10 homolog, NAA11 (ARD2), has been reported to be present in mice and humans, and is co-expressed with NAA10 in human cell lines (Arnesen et al., 2006b). Therefore, NAA11 could conceivably compensate when NAA10 is reduced or lacking (Lee et al., 2018). However, NAA11 was only found in testis and placenta in human and gonadal tissues in mouse, while NAA10 showed widespread expression in various tissues in embryos and adults (Pang et al., 2011). Thus, any functional redundancy or compensation might be limited to certain tissues only.

To elucidate the functional role of Naa10 during development in mice, we used two different Naa10-deficient mouse lines: one, referred to as Naa10 knockout (KO), which was previously reported specifically related to bone density in postnatal day 3 (P3) mice (Yoon et al., 2014), and another denoted as Naa10^{tm1a(EUCOMM)Hmgu} (Naa10^tm1a), generated in this study. These Naa10-deficient mice exhibit pleiotropic developmental abnormalities at a range of different ages, overlapping with some of the phenotypes seen in human disease involving NAA10 impairment. Because we did not discover major changes in the overall Nt-acetylome in Naa10 KO mice, we hypothesized that there might be a compensating gene in mice, which led us to the identification of a new paralog of Naa10, which we name Naa12. Naa12 is expressed in several organs (liver, kidney, heart, and testis) and, like Naa10, binds to Naa15 to mediate NatA activity. Furthermore, lethality was observed in Naa10 Naa12 double-KO mice, which supports the compensatory role of Naa12 in vivo. Thus, we demonstrate that Naa10 is essential for proper development and Naa12, a newly identified paralog of Naa10, can play a compensatory role in mice.

We have shown that Naa10 deficiency results in pleotropic developmental defects in two different Naa10-deficient mouse models. Similar to infant mortality in some OS males, the lethality of Naa10 KO mice increased dramatically in pups in the first three days of life (Figure 1B). Defects in kidney, brain, pigmentation (piebaldism), and ribs were observed during embryonic or early postnatal stages in some mice (Figure 2B, C). These observed phenotypes overlap with some of the phenotypes found in surviving humans with OS, including supernumerary vertebrae and hydrocephaly, although piebaldism has not been reported to date in any humans. However, the puzzling lack of embryonic lethality in the Naa10 KO mice prompted us to discover Naa12 as a possible compensatory NAT, with Naa10-like amino-terminal acetylation activity (Figure 4A), with an interaction between Naa15 and Naa12 (Figure 4B), and with enzymatic activity in a chimeric complex with human NAA15 (Figure 4C). In addition, co-immunoprecipitation of endogenous Naa15 from Naa10 KO mouse tissues followed by mass spectrometry analysis (Table 2) and amino-terminal acetylation assays (Figure 3C) fully supports that the endogenous Naa12-Naa15 complexes produces NatA activity. Finally, we found genetic proof of the compensatory activity of Naa12 in mice when we observed embryonic lethality in in Naa10 Naa12 DKO male and Naa10^+/- Naa12^-/- female mice (Figure 6). This compensation by Naa12 explains the mouse proteomics data indicating normal amino-terminal acetylation in Naa10 KO mice (Figure 3A). We have confirmed the expression of Naa12 in various tissues using qPCR (Figure 4—figure supplement 1A).

Gene duplication has long been believed to be a major driving force in evolution that provides genetic novelty in organisms. Paralogous genes, originating by small-scale or whole-genome duplication, overlap functional roles for each other and can completely or partially compensate for the loss of the duplicate gene (Peng, 2019; Veitia, 2017). There is not yet any human reported with complete KO for NAA10. There is one published truncating variant in the C-terminal portion of NAA10 in a male patient with microphthalmia (Cheng et al., 2019), but unfortunately there are no cell lines available from this family to confirm whether any truncated NAA10 protein is expressed, as was shown with a splice-site mutation in a Lenz microphthalmia family (Esmailpour et al., 2014). NAA10 was also identified in screens for essential genes in human cell lines (Blomen et al., 2015; Wang et al., 2015), so it seems unlikely that an unknown NAA10-like paralogous gene exists in humans, other than the already known NAA11.

The pleiotropic phenotypes shown in Naa10 KO mice, including hypopigmentation and supernumerary ribs with a penetrance of 100%, were not observed in the Naa12 KO mice. Naa10 itself has been described to have N-ɛ-acetyl-activity towards internal lysine residues of proteins involved in various disease- and development-related signaling pathways (Lee et al., 2018), although its acetylation of some substrates is controversial (Magin et al., 2016; Vo, 2020). Since the Nt-acetylome appears to be globally intact in MEFs from Naa10 KO mice (Figure 3A), it is possible that the presented phenotypes could be due to the loss of Naa10-specific N-ɛ-acetyl-activity or non-catalytic roles of Naa10 (Aksnes et al., 2019). Alternatively, the quantitative expression of Naa10 and Naa12 might be different within or between tissues, which might then explain why there is clearly a phenotype for Naa10^+/- Naa12^+/- female mice (not born at Mendelian ratios and the few that are born are usually much smaller) but no apparent phenotype in Naa10^+/+ Naa12^-/- female mice. It seems likely that the mechanism cannot be simply additive between two equally expressed proteins, because if the expression of each protein is theoretically set at an arbitrary unit of 10, then Naa10^+/- Naa12^+/- female mice might possibly have half as much of each protein, so that the total dose of both proteins together would be 10, instead of 20. Likewise, the total dose of both proteins together would also be predicted to be 10 in a Naa10^+/+ Naa12^-/- female. Yet, the Naa10^+/- Naa12^+/- female mice have a phenotype, whereas the Naa10^+/+ Naa12^-/- female mice do not (Figure 6). Therefore, other explanations could include different tissue-specific dosages of each protein, different expression between different tissues, possible X-chromosome skewing for the X-linked Naa10 in different tissues, or different functions of the two enzymes, including Naa10-specific N-ɛ-acetyl-activity or non-catalytic roles of Naa10 (Aksnes et al., 2019). These questions remain unanswered and are worth exploring in future studies. It is worth highlighting that X-chromosome inactivation could certainly be one explanation, given that males that are Naa10^+/Y with Naa12^+/- or Naa12^-/- show expected survival rates, whereas females that are Naa10^+/- with Naa12^+/- show ~35% survival but with Naa12^-/- show 0% survival (Table 4).

There are several clinical features that were presented in the original description of OS (Rope et al., 2011) which can now be better understood in light of the phenotypes found in the KO mouse model. For example, all of the affected children in the first families with OS were noted to have large and, in some cases, persistently open fontanels (Myklebust et al., 2015; Rope et al., 2011). For one child (family 1, individual II-1), CT scanning revealed cerebral atrophy with enlarged ventricles, and in another child (family 1, individual III-4), there was evidence on magnetic resonance imaging (MRI) of ‘moderate lateral and third ventricular dilatation without identified cause.’ Lastly, all of the children had respiratory depression and apneic episodes, along with varying course of hypotonia and/or hypertonia (including documented hyperreflexia in at least one case [family 2, individual III-2]). In retrospect, it seems that these clinical features could be consistent with mild hydrocephaly in these probands with OS, which resolved over time. This is also consistent with the ventriculomegaly reported in several female OS probands with missense mutations in NAA10, along with ventriculomegaly in one other male proband who died in the first week of life, with generalized hypotonia and lack of spontaneous respirations (Saunier et al., 2016). One of the female patients with an Arg83Cys mutation in Naa10 (#9 in Table 1 of that paper) was reported as having intraventricular hemorrhage in the occipital horn, hypoxic-ischemic encephalopathy, and a ventriculo-peritoneal shunt. It is possible that this sequence of events is compatible with hydrocephaly with clinical signs and symptoms that required the placement of the shunt.

There are additional cardiac and skeletal features that are also worth re-examining in light of these new findings. In some of the original cases of OS, there were varying levels of pulmonary valve stenosis detected on echocardiography, along with some documentation of pulmonary hypoplasia (Rope et al., 2011). For example, individual III-7 in family 1 was found on echocardiography to have small persistent ductus arteriosus, a mildly decreased left ventricular systolic function, an abnormal appearing aortic valve, an enlargement of the right ventricle, decreased right ventricular systolic function, and persistence of the foramen ovale. Individual III-6 from this same extended family was found on echocardiography to have a thickened bicuspid aortic valve and mild pulmonary hypertension. One of the OS female patients with an Arg83Cys mutation in NAA10 was reported to have ‘supernumerary vertebrae’ (Saunier et al., 2016). Prompted by our findings of supernumerary ribs in the mice, we obtained an MRI report for this patient, in which the radiologist concluded that there appeared to be 25 distinct vertebrae, as opposed to the usual 24, with a suggestion of a 13th rib, at least on the right. The report went on to state that “the vertebrae represent seven cervical vertebrae, 13 rib-bearing thoracic vertebrae, and five lumbar vertebrae, and the L1 vertebra is mildly dysmorphic, with a suggestion of anterior breaking.” In addition, chest and abdominal X-rays from two of the brothers in generation VI of a family with microphthalmia demonstrated the presence of 13 rib-bearing thoracic vertebrae, alongside the dramatic scoliosis in both individuals. Four other females carrying mutations in Naa10 were reported as having either pectus carinatum or excavatum (Saunier et al., 2016), one of the boys with OS (family 1, individual III-4) was noted to have pectus excavatum, and retrospective review of some of the clinical photographs appears to show mild pectus excavatum in individual III-6 of the same family. Studies of human populations have shown that the levels of transition may be shifted cephalad, resulting in 23 mobile vertebrae, or shifted caudad, resulting in 25 presacral vertebrae. Such variations may occur in 2–11% of the population (Bornstein and Peterson, 1966). In addition, the number of ribs can also vary in mice as a result of teratogenic and genetic influences (Mclaren and Michie, 1958; Chernoff and Rogers, 2004). However, the complete penetrance for supernumerary ribs in the Naa10-deficient mice, along with the presence of extras ribs in some of the patients, suggests that there is a pathway common to humans and mice that is altered by mutations involving NAA10.

Several mouse mutants show similar cardiac or skeletal phenotypes to the Naa10-deficient mice. Pax3 mutants phenocopy our Naa10^-/- mutants as Pax3^+/- adults exhibit 100% piebaldism and exhibit neural crest (NC)-related PTA/DORV with concomitant VSDs (Conway et al., 1997a; Conway et al., 1997b; van den Hoff and Moorman, 2000; Olaopa et al., 2011). Pax3 systemic nulls also have skeletal defects due to abnormal somite morphogenesis (Henderson et al., 1999; Dickman et al., 1999). Moreover, Pax3 cKOs demonstrated that NC-specific deletion is sufficient to cause DORV/VSDs and death at birth (Olaopa et al., 2011; Koushik et al., 2002), and that restricted deletion within the neuroepithelium causes congenital hydrocephalus (Zhou and Conway, 2016). While Pax7 systemic deletion does not cause NC-associated defects, it does exhibit overlapping expression, and Pax3-Pax7 compound heterozygous mice develop hydrocephalus (Zhou and Conway, 2016), suggesting combinatorial function. Hox C8^-/- mice exhibit an extra rib and an extra rib articulating with the sternum (Le Mouellic et al., 1992; Juan and Ruddle, 2003), and an unfused sacral vertebra, which lead to 27 presacral vertebrae (van den Akker et al., 2001), as seen in our model. Hox A4^-/- mice described in Horan et al., 1994 show cervical fusions of C2/C3, a rib on C7 not fully penetrant and sternal defects with bone ossification anomalies. Hox A5^-/- mice display numerous cervico-thoracic defects such as a rib process coming from the seventh cervical vertebra, an increase in the number of sternebrae and total number of ribs (Jeannotte et al., 1993). Both Hox A4^-/- and A5^-/- mice exhibit an extra rib articulating with the sternum. Hox D3^-/- mice are the only Hox gene mutation leading to cervical fusion of both the atlas and axis (Condie and Capecchi, 1993). Hox A9^-/- mice have anteriorization of both sacral and lumbar parts, with an extra pair of ribs at the lumbar level. Hox A9^-/- mice do not have any relevant sternal defect (Fromental-Ramain et al., 1996). Hox B9^-/- mice have an extra rib articulating with the sternum and 14 pairs of rib (Chen and Capecchi, 1997). These phenotypes, especially Hox C8, share common features with the Naa10-deficient mice. This phenotype is also close to the Rpl38^-/- phenotype (Kondrashov et al., 2011), except for the sacral fusion described in Rpl38^-/- mice. Interestingly, it was shown that Hox genes were dysregulated in this genotype. The skeletal findings and comparison to other mutant mice suggest a pattern consistent with a homeotic anterior transformation hypothesis.

The developmental role of Naa10 in mice has been previously described (Lee et al., 2017). Lee et al. reported embryonic lethality at E12.5–14.5 and beyond (due to placental defects), hydrocephaly, postnatal growth retardation, and maternal effect lethality in Naa10 KO mice and suggested that genomic imprinting dysregulation is associated with those developmental phenotypes. In the present study, hydrocephaly and postnatal growth retardation were also apparent, but embryonic lethality was not observed, which prompted the search for and discovery of Naa12. The previous paper (Lee et al., 2017) did not report the piebaldism, homeotic anterior transformation, hydronephrosis, and genital defects (such as seminal vesicle malformation and hydrometrocolpos), nor did it explain the cause of death in the first day of life, which is at least partly due to congenital heart defects, as reported herein. A more recent paper from the same group reported that conventional and adipose-specific Naa10p deletions in mice resulted in increased energy expenditure, thermogenesis, and beige adipocyte differentiation in the surviving mice (Lee et al., 2019), although the authors do not comment on whether any of the male mice used in that study starting at age 5 weeks ended up developing hydrocephaly and/or hydronephrosis, which we have observed in older mice. Although the Lee et al., 2017 paper reported a very high maternal effect lethality rate of 90% (46/51) (otherwise stated as a survival rate of 10% [5/51]) for newborns in matings following Naa10^-/- female and C57BL/6J WT male intercrossing, this rate was only 29% (37/127) in this same mating herein in the first 24 hr of life and with a total death rate in the first three days for all newborns of 46/127, or 36% (Supplementary file 1d), with this result deriving from a larger number of mating pairs, litters, and pups. Although this rate of 36% is higher than that seen with matings involving Naa10^+/- females (15.8% and 13.6%) (Supplementary file 1d), the explanation for this ~20% difference in survival in the first three days of life could involve differences in maternal care provided by the Naa10^+/- and Naa10^-/- females, but this would have to be investigated in future studies, involving detailed behavioral and cognitive assessment of the dams.

The reasons for the differences between the studies in regards to maternal effect lethality and in utero lethality are unknown at present. Whilst Lee et al. deleted Naa10 exons 2–6 (Lee et al., 2017), the current study deleted Naa10 exons 1–4 or used an allele Naa10^tm1a expressing β-galactosidase instead of the Naa10 gene (Figure 1—figure supplement 1D), and there was not any significant embryonic lethality in either line (Supplementary file 1a, b). All three of these mouse models were made using 129Sv/Ev ES cells, and all three are nulls lacking Naa10 protein. It is the case that the previous study used the Cre/loxP system to generate the Naa10 KO mice, where a floxed Naa10 female mouse was crossed with the Ella-Cre transgenic male mouse expressing Cre recombinase for germ line deletion of loxP-flanked Naa10, whereas our mice were made using standard gene-targeting methods without the use of Cre recombinase, but it is not clear how this would have resulted in embryonic lethality, particularly as these mice were only used after ‘at least six generations of backcross with C57BL/6 mice,’ which are noted by the authors to be the substrain C57BL/6JNarl, first established at the Animal Center of National Research Institute from the Jackson Laboratory (JAX) in 1995. The explanation for differences in embryonic lethality might be more likely due to different combinations of modifying alleles that are present in the different C57BL/6J substrain genetic backgrounds, rather than differences in our model systems, and future plans will address this after back-crossing more than 20 generations to C57BL/6J (imported annually from JAX) to achieve an entirely inbred line. The impact of genetic background is supported by the observation that additional null alleles on mixed genetic backgrounds, made during the process of generating missense mouse models for OS, have far less penetrance for a range of the various phenotypes, including much less perinatal lethality (unpublished observations).

In conclusion, our study provides strong evidence that Naa10, the catalytic subunit of NatA, is critical for normal development in mice. Furthermore, this study explains the puzzle regarding the lack of complete embryonic lethality in the Naa10 KO mice due to the discovery of a second mouse Naa10 paralog, which, unlike Naa11, is expressed in the heart as well as other tissues. Taken together, our findings suggest that the newly identified Naa12 can functionally rescue Naa10 loss and act as a catalytic subunit in mouse NatA complexes.

All data generated or analysed during this study are included in the manuscript and supporting files. Mass spectrometry data were uploaded to PRIDE under Project Name: Naa10 mutant mouse N-terminome LC-MS, Project accession: PXD026410 and Project Name: mNaa10-KO liver immunoprecipitation, Project accession: PXD026684.

1. 1. Ju S
   2. Lee C

   (2021) PRIDE

   ID PXD026410. Naa10 mutant mouse N-terminome LC-MS.

   https://www.ebi.ac.uk/pride/archive/projects/PXD026410
2. 1. Ree R
   2. Arnesen T

   (2021) PRIDE

   ID PXD026684. mNaa10-KO liver immunoprecipitation.

   https://www.ebi.ac.uk/pride/archive/projects/PXD026684

1. 1. Aksnes H
   2. Ree R
   3. Arnesen T

   (2019) Co-translational, Post-translational, and Non-catalytic roles of N-Terminal acetyltransferases

   Molecular Cell 73:1097–1114.

   https://doi.org/10.1016/j.molcel.2019.02.007

   • PubMed
   • Google Scholar
2. 1. Arnesen T
   2. Anderson D
   3. Baldersheim C
   4. Lanotte M
   5. Varhaug JE
   6. Lillehaug JR

   (2005) Identification and characterization of the human ARD1-NATH protein acetyltransferase complex

   Biochemical Journal 386:433–443.

   https://doi.org/10.1042/BJ20041071

   • PubMed
   • Google Scholar
3. 1. Arnesen T
   2. Gromyko D
   3. Pendino F
   4. Ryningen A
   5. Varhaug JE
   6. Lillehaug JR

   (2006a) Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex

   Oncogene 25:4350–4360.

   https://doi.org/10.1038/sj.onc.1209469

   • PubMed
   • Google Scholar
4. 1. Arnesen T
   2. Betts MJ
   3. Pendino F
   4. Liberles DA
   5. Anderson D
   6. Caro J
   7. Kong X
   8. Varhaug JE
   9. Lillehaug JR

   (2006b) Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase

   BMC Biochemistry 7:13.

   https://doi.org/10.1186/1471-2091-7-13

   • PubMed
   • Google Scholar
5. 1. Arnesen T
   2. Van Damme P
   3. Polevoda B
   4. Helsens K
   5. Evjenth R
   6. Colaert N
   7. Varhaug JE
   8. Vandekerckhove J
   9. Lillehaug JR
   10. Sherman F
   11. Gevaert K

   (2009) Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans

   PNAS 106:8157–8162.

   https://doi.org/10.1073/pnas.0901931106

   • PubMed
   • Google Scholar
6. 1. Arnesen T
   2. Starheim KK
   3. Van Damme P
   4. Evjenth R
   5. Dinh H
   6. Betts MJ
   7. Ryningen A
   8. Vandekerckhove J
   9. Gevaert K
   10. Anderson D

   (2010) The chaperone-like protein HYPK acts together with NatA in Cotranslational N-terminal acetylation and prevention of huntingtin aggregation

   Molecular and Cellular Biology 30:1898–1909.

   https://doi.org/10.1128/MCB.01199-09

   • PubMed
   • Google Scholar
7. 1. Blomen VA
   2. Májek P
   3. Jae LT
   4. Bigenzahn JW
   5. Nieuwenhuis J
   6. Staring J
   7. Sacco R
   8. van Diemen FR
   9. Olk N
   10. Stukalov A
   11. Marceau C
   12. Janssen H
   13. Carette JE
   14. Bennett KL
   15. Colinge J
   16. Superti-Furga G
   17. Brummelkamp TR

   (2015) Gene essentiality and synthetic lethality in haploid human cells

   Science 350:1092–1096.

   https://doi.org/10.1126/science.aac7557

   • PubMed
   • Google Scholar
8. 1. Bornstein PE
   2. Peterson RR

   (1966) Numerical variation of the presacral vertebral column in three population groups in North America

   American Journal of Physical Anthropology 25:139–146.

   https://doi.org/10.1002/ajpa.1330250205

   • PubMed
   • Google Scholar
9. 1. Casey JP
   2. Støve SI
   3. McGorrian C
   4. Galvin J
   5. Blenski M
   6. Dunne A
   7. Ennis S
   8. Brett F
   9. King MD
   10. Arnesen T
   11. Lynch SA

   (2015) NAA10 mutation causing a novel intellectual disability syndrome with long QT due to N-terminal acetyltransferase impairment

   Scientific Reports 5:16022.

   https://doi.org/10.1038/srep16022

   • PubMed
   • Google Scholar
10. 1. Chen D
    2. Zhang J
    3. Minnerly J
    4. Kaul T
    5. Riddle DL
    6. Jia K

    (2014) daf-31 encodes the catalytic subunit of N Alpha-Acetyltransferase that regulates Caenorhabditis elegans development, metabolism and adult lifespan

    PLOS Genetics 10:e1004699.

    https://doi.org/10.1371/journal.pgen.1004699

    • PubMed
    • Google Scholar
11. 1. Chen H
    2. Li S
    3. Li L
    4. Wu W
    5. Ke X
    6. Zou W
    7. Zhao J

    (2018) Nα-Acetyltransferases 10 and 15 are required for the correct initiation of endosperm cellularization in Arabidopsis

    Plant and Cell Physiology 59:2113–2128.

    https://doi.org/10.1093/pcp/pcy135

    • PubMed
    • Google Scholar
12. 1. Chen F
    2. Capecchi MR

    (1997) Targeted mutations in hoxa-9 and hoxb-9 reveal synergistic interactions

    Developmental Biology 181:186–196.

    https://doi.org/10.1006/dbio.1996.8440

    • PubMed
    • Google Scholar
13. 1. Cheng H
    2. Dharmadhikari AV
    3. Varland S
    4. Ma N
    5. Domingo D
    6. Kleyner R
    7. Rope AF
    8. Yoon M
    9. Stray-Pedersen A
    10. Posey JE
    11. Crews SR
    12. Eldomery MK
    13. Akdemir ZC
    14. Lewis AM
    15. Sutton VR
    16. Rosenfeld JA
    17. Conboy E
    18. Agre K
    19. Xia F
    20. Walkiewicz M
    21. Longoni M
    22. High FA
    23. van Slegtenhorst MA
    24. Mancini GMS
    25. Finnila CR
    26. van Haeringen A
    27. den Hollander N
    28. Ruivenkamp C
    29. Naidu S
    30. Mahida S
    31. Palmer EE
    32. Murray L
    33. Lim D
    34. Jayakar P
    35. Parker MJ
    36. Giusto S
    37. Stracuzzi E
    38. Romano C
    39. Beighley JS
    40. Bernier RA
    41. Küry S
    42. Nizon M
    43. Corbett MA
    44. Shaw M
    45. Gardner A
    46. Barnett C
    47. Armstrong R
    48. Kassahn KS
    49. Van Dijck A
    50. Vandeweyer G
    51. Kleefstra T
    52. Schieving J
    53. Jongmans MJ
    54. de Vries BBA
    55. Pfundt R
    56. Kerr B
    57. Rojas SK
    58. Boycott KM
    59. Person R
    60. Willaert R
    61. Eichler EE
    62. Kooy RF
    63. Yang Y
    64. Wu JC
    65. Lupski JR
    66. Arnesen T
    67. Cooper GM
    68. Chung WK
    69. Gecz J
    70. Stessman HAF
    71. Meng L
    72. Lyon GJ

    (2018) Truncating variants in NAA15 are associated with variable levels of intellectual disability, autism spectrum disorder, and congenital anomalies

    The American Journal of Human Genetics 102:985–994.

    https://doi.org/10.1016/j.ajhg.2018.03.004

    • PubMed
    • Google Scholar
14. 1. Cheng H
    2. Gottlieb L
    3. Marchi E
    4. Kleyner R
    5. Bhardwaj P
    6. Rope AF
    7. Rosenheck S
    8. Moutton S
    9. Philippe C
    10. Eyaid W
    11. Alkuraya FS
    12. Toribio J
    13. Mena R
    14. Prada CE
    15. Stessman H
    16. Bernier R
    17. Wermuth M
    18. Kauffmann B
    19. Blaumeiser B
    20. Kooy RF
    21. Baralle D
    22. Mancini GMS
    23. Conway SJ
    24. Xia F
    25. Chen Z
    26. Meng L
    27. Mihajlovic L
    28. Marmorstein R
    29. Lyon GJ

    (2019) Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15

    Human Molecular Genetics 28:2900–2919.

    https://doi.org/10.1093/hmg/ddz111

    • PubMed
    • Google Scholar
15. 1. Chernoff N
    2. Rogers JM

    (2004) Supernumerary ribs IN developmental toxicity bioassays and IN human populations: incidence and biological significance

    Journal of Toxicology and Environmental Health, Part B 7:437–449.

    https://doi.org/10.1080/10937400490512447

    • Google Scholar
16. 1. Condie BG
    2. Capecchi MR

    (1993) Mice homozygous for a targeted disruption of Hoxd-3 (Hox-4.1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis

    Development 119:579–595.

    https://doi.org/10.1242/dev.119.3.579

    • PubMed
    • Google Scholar
17. 1. Conway SJ
    2. Henderson DJ
    3. Copp AJ

    (1997a) Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant

    Development 124:505–514.

    https://doi.org/10.1242/dev.124.2.505

    • PubMed
    • Google Scholar
18. 1. Conway SJ
    2. Henderson DJ
    3. Kirby ML
    4. Anderson RH
    5. Copp AJ

    (1997b) Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse

    Cardiovascular Research 36:163–173.

    https://doi.org/10.1016/S0008-6363(97)00172-7

    • PubMed
    • Google Scholar
19. 1. Conway SJ
    2. Kruzynska-Frejtag A
    3. Kneer PL
    4. Machnicki M
    5. Koushik SV

    (2003) What cardiovascular defect does my prenatal mouse mutant have, and why?

    Genesis 35:1–21.

    https://doi.org/10.1002/gene.10152

    • PubMed
    • Google Scholar
20. 1. Cox J
    2. Hein MY
    3. Luber CA
    4. Paron I
    5. Nagaraj N
    6. Mann M

    (2014) Accurate Proteome-wide Label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ

    Molecular & Cellular Proteomics 13:2513–2526.

    https://doi.org/10.1074/mcp.M113.031591

    • Google Scholar
21. 1. Cox J
    2. Mann M

    (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

    Nature Biotechnology 26:1367–1372.

    https://doi.org/10.1038/nbt.1511

    • PubMed
    • Google Scholar
22. 1. Dehairs J
    2. Talebi A
    3. Cherifi Y
    4. Swinnen JV

    (2016) CRISP-ID: decoding CRISPR mediated indels by Sanger sequencing

    Scientific Reports 6:28973.

    https://doi.org/10.1038/srep28973

    • PubMed
    • Google Scholar
23. 1. Dickman ED
    2. Rogers R
    3. Conway SJ

    (1999) Abnormal skeletogenesis occurs coincident with increased apoptosis in the splotch (Sp2H) mutant: putative roles for Pax3 and PDGFRalpha in rib patterning

    The Anatomical Record 255:353–361.

    https://doi.org/10.1002/(SICI)1097-0185(19990701)255:3<353::AID-AR11>3.0.CO;2-H

    • PubMed
    • Google Scholar
24. 1. Dikiy I
    2. Eliezer D

    (2014) N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes

    Journal of Biological Chemistry 289:3652–3665.

    https://doi.org/10.1074/jbc.M113.512459

    • PubMed
    • Google Scholar
25. 1. Dörfel MJ
    2. Fang H
    3. Crain J
    4. Klingener M
    5. Weiser J
    6. Lyon GJ

    (2017) Proteomic and genomic characterization of a yeast model for ogden syndrome

    Yeast 34:19–37.

    https://doi.org/10.1002/yea.3211

    • PubMed
    • Google Scholar
26. 1. Dörfel MJ
    2. Lyon GJ

    (2015) The biological functions of Naa10 - From amino-terminal acetylation to human disease

    Gene 567:103–131.

    https://doi.org/10.1016/j.gene.2015.04.085

    • PubMed
    • Google Scholar
27. 1. Esmailpour T
    2. Riazifar H
    3. Liu L
    4. Donkervoort S
    5. Huang VH
    6. Madaan S
    7. Shoucri BM
    8. Busch A
    9. Wu J
    10. Towbin A
    11. Chadwick RB
    12. Sequeira A
    13. Vawter MP
    14. Sun G
    15. Johnston JJ
    16. Biesecker LG
    17. Kawaguchi R
    18. Sun H
    19. Kimonis V
    20. Huang T

    (2014) A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes lenz microphthalmia syndrome

    Journal of Medical Genetics 51:185–196.

    https://doi.org/10.1136/jmedgenet-2013-101660

    • PubMed
    • Google Scholar
28. 1. Feng J
    2. Li R
    3. Yu J
    4. Ma S
    5. Wu C
    6. Li Y
    7. Cao Y
    8. Ma L

    (2016) Protein N-terminal acetylation is required for embryogenesis in Arabidopsis

    Journal of Experimental Botany 67:4779–4789.

    https://doi.org/10.1093/jxb/erw257

    • PubMed
    • Google Scholar
29. 1. Foyn H
    2. Jones JE
    3. Lewallen D
    4. Narawane R
    5. Varhaug JE
    6. Thompson PR
    7. Arnesen T

    (2013) Design, synthesis, and kinetic characterization of protein N-terminal acetyltransferase inhibitors

    ACS Chemical Biology 8:1121–1127.

    https://doi.org/10.1021/cb400136s

    • PubMed
    • Google Scholar
30. 1. Fromental-Ramain C
    2. Warot X
    3. Lakkaraju S
    4. Favier B
    5. Haack H
    6. Birling C
    7. Dierich A
    8. Doll e P
    9. Chambon P

    (1996) Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeleton patterning

    Development 122:461–472.

    https://doi.org/10.1242/dev.122.2.461

    • PubMed
    • Google Scholar
31. 1. Gautschi M
    2. Just S
    3. Mun A
    4. Ross S
    5. Rücknagel P
    6. Dubaquié Y
    7. Ehrenhofer-Murray A
    8. Rospert S

    (2003) The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides

    Molecular and Cellular Biology 23:7403–7414.

    https://doi.org/10.1128/MCB.23.20.7403-7414.2003

    • PubMed
    • Google Scholar
32. 1. Gendron RL
    2. Laver NV
    3. Good WV
    4. Grossniklaus HE
    5. Miskiewicz E
    6. Whelan MA
    7. Walker J
    8. Paradis H

    (2010) Loss of tubedown expression as a contributing factor in the development of age-related retinopathy

    Investigative Opthalmology & Visual Science 51:5267–5277.

    https://doi.org/10.1167/iovs.09-4527

    • PubMed
    • Google Scholar
33. 1. Gottlieb L
    2. Marmorstein R

    (2018) Structure of human NatA and its regulation by the huntingtin interacting protein HYPK

    Structure 26:925–935.

    https://doi.org/10.1016/j.str.2018.04.003

    • PubMed
    • Google Scholar
34. 1. Henderson DJ
    2. Conway SJ
    3. Copp AJ

    (1999) Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite

    Developmental Biology 209:143–158.

    https://doi.org/10.1006/dbio.1999.9215

    • PubMed
    • Google Scholar
35. 1. Holmes WM
    2. Mannakee BK
    3. Gutenkunst RN
    4. Serio TR

    (2014) Loss of amino-terminal acetylation suppresses a prion phenotype by modulating global protein folding

    Nature Communications 5:4383.

    https://doi.org/10.1038/ncomms5383

    • PubMed
    • Google Scholar
36. 1. Horan GS
    2. Wu K
    3. Wolgemuth DJ
    4. Behringer RR

    (1994) Homeotic transformation of cervical vertebrae in Hoxa-4 mutant mice

    PNAS 91:12644–12648.

    https://doi.org/10.1073/pnas.91.26.12644

    • PubMed
    • Google Scholar
37. 1. Ingram AK
    2. Cross GA
    3. Horn D

    (2000) Genetic manipulation indicates that ARD1 is an essential N(alpha)-acetyltransferase in Trypanosoma brucei

    Molecular and Biochemical Parasitology 111:309–317.

    https://doi.org/10.1016/S0166-6851(00)00322-4

    • PubMed
    • Google Scholar
38. 1. Jeannotte L
    2. Lemieux M
    3. Charron J
    4. Poirier F
    5. Robertson EJ

    (1993) Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene

    Genes & Development 7:2085–2096.

    https://doi.org/10.1101/gad.7.11.2085

    • PubMed
    • Google Scholar
39. 1. Johnston JJ
    2. Williamson KA
    3. Chou CM
    4. Sapp JC
    5. Ansari M
    6. Chapman HM
    7. Cooper DN
    8. Dabir T
    9. Dudley JN
    10. Holt RJ
    11. Ragge NK
    12. Schäffer AA
    13. Sen SK
    14. Slavotinek AM
    15. FitzPatrick DR
    16. Glaser TM
    17. Stewart F
    18. Black GC
    19. Biesecker LG

    (2019) NAA10 polyadenylation signal variants cause syndromic microphthalmia

    Journal of Medical Genetics 56:444–452.

    https://doi.org/10.1136/jmedgenet-2018-105836

    • PubMed
    • Google Scholar
40. 1. Ju S
    2. Kwon Y
    3. Kim JM
    4. Park D
    5. Lee S
    6. Lee JW
    7. Hwang CS
    8. Lee C

    (2020) iNrich, rapid and robust method to enrich N-Terminal proteome in a highly multiplexed platform

    Analytical Chemistry 92:6462–6469.

    https://doi.org/10.1021/acs.analchem.9b05653

    • PubMed
    • Google Scholar
41. 1. Juan AH
    2. Ruddle FH

    (2003) Enhancer timing of hox gene expression: deletion of the endogenous Hoxc8 early enhancer

    Development 130:4823–4834.

    https://doi.org/10.1242/dev.00672

    • PubMed
    • Google Scholar
42. 1. Kim SH
    2. Park JA
    3. Kim JH
    4. Lee JW
    5. Seo JH
    6. Jung BK
    7. Chun KH
    8. Jeong JW
    9. Bae MK
    10. Kim KW

    (2006) Characterization of ARD1 variants in mammalian cells

    Biochemical and Biophysical Research Communications 340:422–427.

    https://doi.org/10.1016/j.bbrc.2005.12.018

    • PubMed
    • Google Scholar
43. 1. Kondrashov N
    2. Pusic A
    3. Stumpf CR
    4. Shimizu K
    5. Hsieh AC
    6. Ishijima J
    7. Shiroishi T
    8. Barna M

    (2011) Ribosome-mediated specificity in hox mRNA translation and vertebrate tissue patterning

    Cell 145:383–397.

    https://doi.org/10.1016/j.cell.2011.03.028

    • PubMed
    • Google Scholar
44. 1. Koushik SV
    2. Chen H
    3. Wang J
    4. Conway SJ

    (2002) Generation of a conditional loxP allele of the Pax3 transcription factor that enables selective deletion of the homeodomain

    Genesis 32:114–117.

    https://doi.org/10.1002/gene.10051

    • PubMed
    • Google Scholar
45. 1. Le Mouellic H
    2. Lallemand Y
    3. Brûlet P

    (1992) Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene

    Cell 69:251–264.

    https://doi.org/10.1016/0092-8674(92)90406-3

    • PubMed
    • Google Scholar
46. 1. Lee CC
    2. Peng SH
    3. Shen L
    4. Lee CF
    5. Du TH
    6. Kang ML
    7. Xu GL
    8. Upadhyay AK
    9. Cheng X
    10. Yan YT
    11. Zhang Y
    12. Juan LJ

    (2017) The role of N-α-acetyltransferase 10 protein in DNA methylation and genomic imprinting

    Molecular Cell 68:89–103.

    https://doi.org/10.1016/j.molcel.2017.08.025

    • PubMed
    • Google Scholar
47. 1. Lee M-N
    2. Kweon HY
    3. Oh GT

    (2018) N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10

    Experimental & Molecular Medicine 50:1–11.

    https://doi.org/10.1038/s12276-018-0105-2

    • Google Scholar
48. 1. Lee CC
    2. Shih YC
    3. Kang ML
    4. Chang YC
    5. Chuang LM
    6. Devaraj R
    7. Juan LJ

    (2019) Naa10p inhibits beige Adipocyte-Mediated thermogenesis through N-α-acetylation of Pgc1α

    Molecular Cell 76:500–515.

    https://doi.org/10.1016/j.molcel.2019.07.026

    • PubMed
    • Google Scholar
49. 1. Linster E
    2. Stephan I
    3. Bienvenut WV
    4. Maple-Grødem J
    5. Myklebust LM
    6. Huber M
    7. Reichelt M
    8. Sticht C
    9. Møller SG
    10. Meinnel T
    11. Arnesen T
    12. Giglione C
    13. Hell R
    14. Wirtz M

    (2015) Downregulation of N-terminal acetylation triggers ABA-mediated drought responses in Arabidopsis

    Nature Communications 6:7640.

    https://doi.org/10.1038/ncomms8640

    • PubMed
    • Google Scholar
50. 1. Liszczak G
    2. Goldberg JM
    3. Foyn H
    4. Petersson EJ
    5. Arnesen T
    6. Marmorstein R

    (2013) Molecular basis for N-terminal acetylation by the heterodimeric NatA complex

    Nature Structural & Molecular Biology 20:1098–1105.

    https://doi.org/10.1038/nsmb.2636

    • PubMed
    • Google Scholar
51. 1. Magin RS
    2. March ZM
    3. Marmorstein R

    (2016) The N-terminal acetyltransferase Naa10/ARD1 does not acetylate lysine residues

    Journal of Biological Chemistry 291:5270–5277.

    https://doi.org/10.1074/jbc.M115.709428

    • PubMed
    • Google Scholar
52. 1. Magin RS
    2. Deng S
    3. Zhang H
    4. Cooperman B
    5. Marmorstein R

    (2017) Probing the interaction between NatA and the ribosome for co-translational protein acetylation

    PLOS ONE 12:e0186278.

    https://doi.org/10.1371/journal.pone.0186278

    • PubMed
    • Google Scholar
53. 1. Mclaren A
    2. Michie D

    (1958)

    Factors affecting vertebral variation in mice. 4. experimental proof of the uterine basis of a maternal effect

    Journal of Embryology and Experimental Morphology 6:645–659.

    • PubMed
    • Google Scholar
54. 1. McTiernan N
    2. Støve SI
    3. Aukrust I
    4. Mårli MT
    5. Myklebust LM
    6. Houge G
    7. Arnesen T

    (2018) NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report

    BMC Medical Genetics 19:47.

    https://doi.org/10.1186/s12881-018-0559-z

    • PubMed
    • Google Scholar
55. 1. Mullen JR
    2. Kayne PS
    3. Moerschell RP
    4. Tsunasawa S
    5. Gribskov M
    6. Colavito-Shepanski M
    7. Grunstein M
    8. Sherman F
    9. Sternglanz R

    (1989) Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast

    The EMBO Journal 8:2067–2075.

    https://doi.org/10.1002/j.1460-2075.1989.tb03615.x

    • PubMed
    • Google Scholar
56. 1. Myklebust LM
    2. Van Damme P
    3. Støve SI
    4. Dörfel MJ
    5. Abboud A
    6. Kalvik TV
    7. Grauffel C
    8. Jonckheere V
    9. Wu Y
    10. Swensen J
    11. Kaasa H
    12. Liszczak G
    13. Marmorstein R
    14. Reuter N
    15. Lyon GJ
    16. Gevaert K
    17. Arnesen T

    (2015) Biochemical and cellular analysis of ogden syndrome reveals downstream Nt-acetylation defects

    Human Molecular Genetics 24:1956–1976.

    https://doi.org/10.1093/hmg/ddu611

    • PubMed
    • Google Scholar
57. 1. Olaopa M
    2. Zhou HM
    3. Snider P
    4. Wang J
    5. Schwartz RJ
    6. Moon AM
    7. Conway SJ

    (2011) Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation

    Developmental Biology 356:308–322.

    https://doi.org/10.1016/j.ydbio.2011.05.583

    • PubMed
    • Google Scholar
58. 1. Pang AL
    2. Clark J
    3. Chan WY
    4. Rennert OM

    (2011) Expression of human NAA11 (ARD1B) gene is tissue-specific and is regulated by DNA methylation

    Epigenetics 6:1391–1399.

    https://doi.org/10.4161/epi.6.11.18125

    • PubMed
    • Google Scholar
59. 1. Park EC
    2. Szostak JW

    (1992) ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity

    The EMBO Journal 11:2087–2093.

    https://doi.org/10.1002/j.1460-2075.1992.tb05267.x

    • PubMed
    • Google Scholar
60. 1. Peng J

    (2019) Gene redundancy and gene compensation: an updated view

    Journal of Genetics and Genomics 46:329–333.

    https://doi.org/10.1016/j.jgg.2019.07.001

    • PubMed
    • Google Scholar
61. 1. Polevoda B
    2. Arnesen T
    3. Sherman F

    (2009) A synopsis of eukaryotic Nalpha-terminal acetyltransferases: nomenclature, subunits and substrates

    BMC Proceedings 3:S2.

    https://doi.org/10.1186/1753-6561-3-s6-s2

    • PubMed
    • Google Scholar
62. 1. Polevoda B
    2. Sherman F

    (2003) Composition and function of the eukaryotic N-terminal acetyltransferase subunits

    Biochemical and Biophysical Research Communications 308:1–11.

    https://doi.org/10.1016/S0006-291X(03)01316-0

    • PubMed
    • Google Scholar
63. 1. Popp B
    2. Støve SI
    3. Endele S
    4. Myklebust LM
    5. Hoyer J
    6. Sticht H
    7. Azzarello-Burri S
    8. Rauch A
    9. Arnesen T
    10. Reis A

    (2015) De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females

    European Journal of Human Genetics 23:602–609.

    https://doi.org/10.1038/ejhg.2014.150

    • PubMed
    • Google Scholar
64. 1. Pun A
    2. Cervantes I
    3. Nieto B
    4. Salgado C
    5. Pérez-Cabal MA
    6. Ibáñez-Escriche N
    7. Gutiérrez JP

    (2013) Genetic parameters for birthweight environmental variability in mice

    Journal of Animal Breeding and Genetics 130:404–414.

    https://doi.org/10.1111/jbg.12021

    • PubMed
    • Google Scholar
65. 1. Qiu P
    2. Shandilya H
    3. D'Alessio JM
    4. O'Connor K
    5. Durocher J
    6. Gerard GF

    (2004) Mutation detection using surveyor nuclease

    BioTechniques 36:702–707.

    https://doi.org/10.2144/04364PF01

    • PubMed
    • Google Scholar
66. 1. Rappsilber J
    2. Mann M
    3. Ishihama Y

    (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips

    Nature Protocols 2:1896–1906.

    https://doi.org/10.1038/nprot.2007.261

    • PubMed
    • Google Scholar
67. 1. Ree R
    2. Myklebust LM
    3. Thiel P
    4. Foyn H
    5. Fladmark KE
    6. Arnesen T

    (2015) The N-terminal acetyltransferase Naa10 is essential for zebrafish development

    Bioscience Reports 35:e00249.

    https://doi.org/10.1042/BSR20150168

    • Google Scholar
68. 1. Ree R
    2. Varland S
    3. Arnesen T

    (2018) Spotlight on protein N-terminal acetylation

    Experimental & Molecular Medicine 50:1–13.

    https://doi.org/10.1038/s12276-018-0116-z

    • PubMed
    • Google Scholar
69. 1. Ree R
    2. Geithus AS
    3. Tørring PM
    4. Sørensen KP
    5. Damkjær M
    6. Lynch SA
    7. Arnesen T
    8. DDD study

    (2019) A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly

    BMC Medical Genetics 20:101.

    https://doi.org/10.1186/s12881-019-0803-1

    • PubMed
    • Google Scholar
70. 1. Rope AF
    2. Wang K
    3. Evjenth R
    4. Xing J
    5. Johnston JJ
    6. Swensen JJ
    7. Johnson WE
    8. Moore B
    9. Huff CD
    10. Bird LM
    11. Carey JC
    12. Opitz JM
    13. Stevens CA
    14. Jiang T
    15. Schank C
    16. Fain HD
    17. Robison R
    18. Dalley B
    19. Chin S
    20. South ST
    21. Pysher TJ
    22. Jorde LB
    23. Hakonarson H
    24. Lillehaug JR
    25. Biesecker LG
    26. Yandell M
    27. Arnesen T
    28. Lyon GJ

    (2011) Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency

    The American Journal of Human Genetics 89:28–43.

    https://doi.org/10.1016/j.ajhg.2011.05.017

    • PubMed
    • Google Scholar
71. 1. Saunier C
    2. Støve SI
    3. Popp B
    4. Gérard B
    5. Blenski M
    6. AhMew N
    7. de Bie C
    8. Goldenberg P
    9. Isidor B
    10. Keren B
    11. Leheup B
    12. Lampert L
    13. Mignot C
    14. Tezcan K
    15. Mancini GM
    16. Nava C
    17. Wasserstein M
    18. Bruel AL
    19. Thevenon J
    20. Masurel A
    21. Duffourd Y
    22. Kuentz P
    23. Huet F
    24. Rivière JB
    25. van Slegtenhorst M
    26. Faivre L
    27. Piton A
    28. Reis A
    29. Arnesen T
    30. Thauvin-Robinet C
    31. Zweier C

    (2016) Expanding the phenotype associated with NAA10-Related N-Terminal acetylation deficiency

    Human Mutation 37:755–764.

    https://doi.org/10.1002/humu.23001

    • PubMed
    • Google Scholar
72. 1. Scott DC
    2. Monda JK
    3. Bennett EJ
    4. Harper JW
    5. Schulman BA

    (2011) N-terminal acetylation acts as an avidity enhancer within an interconnected multiprotein complex

    Science 334:674–678.

    https://doi.org/10.1126/science.1209307

    • PubMed
    • Google Scholar
73. 1. Shemorry A
    2. Hwang CS
    3. Varshavsky A

    (2013) Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway

    Molecular Cell 50:540–551.

    https://doi.org/10.1016/j.molcel.2013.03.018

    • PubMed
    • Google Scholar
74. 1. Singh P
    2. Schimenti JC
    3. Bolcun-Filas E

    (2015) A mouse geneticist's practical guide to CRISPR applications

    Genetics 199:1–15.

    https://doi.org/10.1534/genetics.114.169771

    • PubMed
    • Google Scholar
75. 1. Starheim KK
    2. Gevaert K
    3. Arnesen T

    (2012) Protein N-terminal acetyltransferases: when the start matters

    Trends in Biochemical Sciences 37:152–161.

    https://doi.org/10.1016/j.tibs.2012.02.003

    • PubMed
    • Google Scholar
76. 1. Støve SI
    2. Blenski M
    3. Stray-Pedersen A
    4. Wierenga KJ
    5. Jhangiani SN
    6. Akdemir ZC
    7. Crawford D
    8. McTiernan N
    9. Myklebust LM
    10. Purcarin G
    11. McNall-Knapp R
    12. Wadley A
    13. Belmont JW
    14. Kim JJ
    15. Lupski JR
    16. Arnesen T

    (2018) A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy

    European Journal of Human Genetics 26:1294–1305.

    https://doi.org/10.1038/s41431-018-0136-0

    • PubMed
    • Google Scholar
77. 1. Sugiura N
    2. Adams SM
    3. Corriveau RA

    (2003) An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development

    Journal of Biological Chemistry 278:40113–40120.

    https://doi.org/10.1074/jbc.M301218200

    • PubMed
    • Google Scholar
78. 1. Van Damme P
    2. Hole K
    3. Pimenta-Marques A
    4. Helsens K
    5. Vandekerckhove J
    6. Martinho RG
    7. Gevaert K
    8. Arnesen T

    (2011a) NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation

    PLOS Genetics 7:e1002169.

    https://doi.org/10.1371/journal.pgen.1002169

    • PubMed
    • Google Scholar
79. 1. Van Damme P
    2. Evjenth R
    3. Foyn H
    4. Demeyer K
    5. De Bock PJ
    6. Lillehaug JR
    7. Vandekerckhove J
    8. Arnesen T
    9. Gevaert K

    (2011b) Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase

    Molecular & Cellular Proteomics 10:M110.004580.

    https://doi.org/10.1074/mcp.M110.004580

    • PubMed
    • Google Scholar
80. 1. Van Damme P
    2. Støve SI
    3. Glomnes N
    4. Gevaert K
    5. Arnesen T

    (2014) A Saccharomyces cerevisiae model reveals in vivo functional impairment of the ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant

    Molecular & Cellular Proteomics 13:2031–2041.

    https://doi.org/10.1074/mcp.M113.035402

    • PubMed
    • Google Scholar
81. 1. van den Akker E
    2. Fromental-Ramain C
    3. de Graaff W
    4. Le Mouellic H
    5. Brûlet P
    6. Chambon P
    7. Deschamps J

    (2001) Axial skeletal patterning in mice lacking all paralogous group 8 hox genes

    Development 128:1911–1921.

    https://doi.org/10.1242/dev.128.10.1911

    • PubMed
    • Google Scholar
82. 1. van den Hoff MJ
    2. Moorman AF

    (2000) Cardiac neural crest: the holy grail of cardiac abnormalities?

    Cardiovascular Research 47:212–216.

    https://doi.org/10.1016/S0008-6363(00)00127-9

    • PubMed
    • Google Scholar
83. 1. Varland S
    2. Arnesen T

    (2018) Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae

    BMC Research Notes 11:404.

    https://doi.org/10.1186/s13104-018-3513-4

    • PubMed
    • Google Scholar
84. 1. Veitia RA

    (2017) Gene duplicates: agents of robustness or fragility?

    Trends in Genetics 33:377–379.

    https://doi.org/10.1016/j.tig.2017.03.006

    • PubMed
    • Google Scholar
85. 1. Vo TTL

    (2020) Characterization of lysine acetyltransferase activity of recombinant human ARD1/NAA10

    Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry 25:588.

    https://doi.org/10.3390/molecules25030588

    • Google Scholar
86. 1. Wang Y
    2. Mijares M
    3. Gall MD
    4. Turan T
    5. Javier A
    6. Bornemann DJ
    7. Manage K
    8. Warrior R

    (2010) Drosophila variable nurse cells encodes arrest defective 1 (ARD1), the catalytic subunit of the major N-terminal acetyltransferase complex

    Developmental Dynamics 239:2813–2827.

    https://doi.org/10.1002/dvdy.22418

    • PubMed
    • Google Scholar
87. 1. Wang T
    2. Birsoy K
    3. Hughes NW
    4. Krupczak KM
    5. Post Y
    6. Wei JJ
    7. Lander ES
    8. Sabatini DM

    (2015) Identification and characterization of essential genes in the human genome

    Science 350:1096–1101.

    https://doi.org/10.1126/science.aac7041

    • PubMed
    • Google Scholar
88. 1. Ward T
    2. Tai W
    3. Morton S
    4. Impens F
    5. Van Damme P
    6. Van Haver D
    7. Timmerman E
    8. Venturini G
    9. Zhang K
    10. Jang MY
    11. Willcox JAL
    12. Haghighi A
    13. Gelb BD
    14. Chung WK
    15. Goldmuntz E
    16. Porter GA
    17. Lifton RP
    18. Brueckner M
    19. Yost HJ
    20. Bruneau BG
    21. Gorham J
    22. Kim Y
    23. Pereira A
    24. Homsy J
    25. Benson CC
    26. DePalma SR
    27. Varland S
    28. Chen CS
    29. Arnesen T
    30. Gevaert K
    31. Seidman C
    32. Seidman JG

    (2021) Mechanisms of congenital heart disease caused by NAA15 haploinsufficiency

    Circulation Research 128:1156–1169.

    https://doi.org/10.1161/CIRCRESAHA.120.316966

    • PubMed
    • Google Scholar
89. 1. Wiśniewski JR
    2. Zougman A
    3. Nagaraj N
    4. Mann M

    (2009) Universal sample preparation method for proteome analysis

    Nature Methods 6:359–362.

    https://doi.org/10.1038/nmeth.1322

    • PubMed
    • Google Scholar
90. 1. Wu Y
    2. Lyon GJ

    (2018) NAA10-related syndrome

    Experimental & Molecular Medicine 50:1–10.

    https://doi.org/10.1038/s12276-018-0098-x

    • Google Scholar
91. 1. Yoon H
    2. Kim HL
    3. Chun YS
    4. Shin DH
    5. Lee KH
    6. Shin CS
    7. Lee DY
    8. Kim HH
    9. Lee ZH
    10. Ryoo HM
    11. Lee MN
    12. Oh GT
    13. Park JW

    (2014) NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2

    Nature Communications 5:5176.

    https://doi.org/10.1038/ncomms6176

    • PubMed
    • Google Scholar
92. 1. Zeger SL
    2. Liang KY

    (1986) Longitudinal data analysis for discrete and continuous outcomes

    Biometrics 42:121–130.

    https://doi.org/10.2307/2531248

    • PubMed
    • Google Scholar
93. 1. Zhou HM
    2. Conway SJ

    (2016) Restricted Pax3 deletion within the neural tube results in congenital hydrocephalus

    Journal of Developmental Biology 4:7.

    https://doi.org/10.3390/jdb4010007

    • PubMed
    • Google Scholar

Author details

1. Hyae Yon Kweon

   Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

   Contribution

   Formal analysis, Investigation, Writing - original draft, Writing - review and editing

   Contributed equally with

   Mi-Ni Lee

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-1534-0767

2. Mi-Ni Lee

   1. Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea
   2. Laboratory Animal Resource Center Korea ResearchInstitute of Bioscience and Biotechnology, Chungbuk, Republic of Korea

   Present address

   Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk, Republic of Korea

   Contribution

   Supervision, Investigation, Project administration, Writing - review and editing

   Contributed equally with

   Hyae Yon Kweon

   For correspondence

   minilee@kribb.re.kr

   Competing interests

   No competing interests declared

3. Max Dorfel

   Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

   Contribution

   Investigation

   Competing interests

   No competing interests declared

4. Seungwoon Seo

   Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

   Contribution

   Investigation

   Competing interests

   No competing interests declared

5. Leah Gottlieb

   1. Department of Chemistry, University of Pennsylvania, Philadelphia, United States
   2. Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States

   Contribution

   Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

6. Thomas PaPazyan

   Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

   Contribution

   Investigation

   Competing interests

   No competing interests declared

7. Nina McTiernan

   Department of Biomedicine, University of Bergen, Bergen, Norway

   Contribution

   Investigation

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-1749-6933

8. Rasmus Ree

   Department of Biomedicine, University of Bergen, Bergen, Norway

   Contribution

   Investigation

   Competing interests

   No competing interests declared

9. David Bolton

   Department of Molecular Biology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States

   Contribution

   Formal analysis, Writing - review and editing

   Competing interests

   No competing interests declared

10. Andrew Garcia

    Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

11. Michael Flory

    Research Design and Analysis Service, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

12. Jonathan Crain

    Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

13. Alison Sebold

    Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

14. Scott Lyons

    Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

15. Ahmed Ismail

    Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

16. Elaine Marchi

    Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

17. Seong-keun Sonn

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

18. Se-Jin Jeong

    Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-6375-5334

19. Sejin Jeon

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-3819-3421

20. Shinyeong Ju

    Center for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-5483-4690

21. Simon J Conway

    Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, United States

    Contribution

    Investigation

    Competing interests

    No competing interests declared

22. Taesoo Kim

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-3902-1058

23. Hyun-Seok Kim

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

24. Cheolju Lee

    1. Center for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic of Korea
    2. Department of Converging Science and Technology, KHU-KIST, Kyung Hee University, Seoul, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-8482-4696

25. Tae-Young Roh

    Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-5833-0844

26. Thomas Arnesen

    1. Department of Biomedicine, University of Bergen, Bergen, Norway
    2. Department of Biological Sciences, University of Bergen, Bergen, Norway
    3. Department of Surgery, Haukeland University Hospital, Bergen, Norway

    Contribution

    Supervision, Writing - review and editing

    Competing interests

    No competing interests declared

27. Ronen Marmorstein

    1. Department of Chemistry, University of Pennsylvania, Philadelphia, United States
    2. Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
    3. Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States

    Contribution

    Supervision, Writing - review and editing

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0003-4373-4752

28. Goo Taeg Oh

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea

    Contribution

    Funding acquisition, Project administration, Writing - review and editing

    For correspondence

    gootaeg@ewha.ac.kr

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-1104-1698

29. Gholson J Lyon

    1. Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    2. Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    3. Biology PhD Program, The Graduate Center, The City University of New York, New York, United States
    4. George A. Jervis Clinic, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States

    Contribution

    Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing

    For correspondence

    gholsonjlyon@gmail.com

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-5869-0716

• 1,351

  views

• 188

  downloads

• 9

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.